期刊文献+

六种抗精神病药物对精神分裂症患者糖脂代谢的影响研究 被引量:14

下载PDF
导出
摘要 目前,药物治疗是精神分裂症的关键,非典型抗精神病药物因其安全、有效特点被广泛用于精神分裂症的治疗.近年来,由其引发的糖脂代谢不良影响给患者造成一定痛苦并引起临床医生们的关注.国内外有不少关于抗精神病药物对糖脂代谢影响的报道,但缺乏多种药物间的比较.本研究比较了6种非典型抗精神病药物对精神分裂症患者糖脂代谢的影响,现报告如下.
出处 《中国药物与临床》 CAS 2015年第9期1324-1326,共3页 Chinese Remedies & Clinics
  • 相关文献

参考文献21

  • 1Lieberman JA.Effectiveness of antipsychotic drugs in patients with chronic schizophrenia:efficacy,safety and cost outcomes of CATIE and other trials[J].J Clin Psychiatry,2007,68:e4.
  • 2Geddes J,Freemantle N,Harrison P,et al.Atypical antipsychotics in the treatment of schizophrenia;systematic overview and meta-regression analysis[J].BMJ,2000,321(7273):1371-1376.
  • 3Lieberman JA,Stroup TS.Mcevoy effectiveness of antipsychotic drugs in patients with chronic schizophrenia[J].N Engl J Med,2005,353(12):1209-1223.
  • 4Fontaine KR,Heo M,Harrigan EP,et al.Estimating the consequences of antipsychotic induced weight gain on health and mortality rate[J].Psychiatry Res,2001,101(3):277-288.
  • 5Wirshing DA.Schizophrenia and obesity:impact of antipsychotic medications[J].J Clin Psychiatry,2004,65(Suppl 18):13-26.
  • 6American Diabetes Association,American Psychiatric Association,American Association of Clinical Endocrinologists,North American Association for the Study of Obesity.Consensus development conference on antipsychotic drugs and obesity and diabetes[J].J Clin Psychiatry,2004,65(2):267-272.
  • 7Baptista T,Kin NM,Beaulieu S,et al.Obesity and related metabolic abnormalities during antipsychotic drug[J].Natl Med J,2010,01:682.
  • 8Lamiae GB,Frederic R,Bernard A,et al.Dose long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia?Results of the Cohort for the General study of Schizophrenia(CGS)[J].Schizophr Res,2012,134(2):187-194.
  • 9刘洪光,曾志强,王元彬,叶昌斌.利培酮和氯氮平治疗精神分裂症疗效评价及其对糖、脂代谢的影响分析[J].国际检验医学杂志,2013,34(1):33-35. 被引量:14
  • 10陈修哲,杨晓华,陈建平,高蕊,杨晓东,郝维德.抗精神病药物对精神分裂症患者血脂、血糖和体重影响的研究[J].山东精神医学,2006,19(1):11-13. 被引量:19

二级参考文献117

  • 1刘燕,李华芳,王慧芳,王克勋,高哲石,顾牛范.氯氮平、利培酮对精神分裂症病人血糖-胰岛素稳态的影响及相关因素分析[J].上海精神医学,2003,15(5):257-259. 被引量:33
  • 2梁颖杰,王传跃.氯氮平致脑电图异常及癫癎发作的文献回顾[J].临床精神医学杂志,2006,16(2):78-79. 被引量:9
  • 3陈立成,杨瑞明,姜国柱,屈广胜,谷士强.PANSS在罹患精神分裂症罪犯中的试用[J].临床心身疾病杂志,2007,13(1):23-24. 被引量:3
  • 4柯士凤,昂惠玲,李春英,郁缪宇.抗精神病药对血脂的影响[J].上海精神医学,1996,8(1):34-35. 被引量:25
  • 5Cutler A J, Kalali AH, Weiden PJ, et al. Four-week, doubleblind, placebo- and ziprasidone-controlled trial of itoperidone in patients with acute exacerbations of schizophrenia [ J ]. J Clin Psychopharmacol, 2008, 28 (2 Suppl 1 ) :S20-28.
  • 6Davidson M, Emsley R, Kramer M, et al. Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER) : results of a 6-week, randomized, placebo-controlled study [ J ]. Schizophr Res, 2007, 93 ( 1 ) : 117- 130.
  • 7Kane J, Canas F, Kramer M, et al. Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial [ J ]. Schizophr Res, 2007,90 ( 1 ) : 147-161.
  • 8Keck PE, Orsulak PJ, Cutler A J, etal. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study [J]. J Affect Disord, 2009, 112( 1 ) :36-49.
  • 9Kryzhanovskaya L, Schulz SC, McDougle C, et al. Olanzapine versus placebo in adolescents with schizophrenia: a 6- week, randomized, double-blind, placebo-controlled trial [J]. J Am Acad Child Adolesc Psychiatry, 2009, 48 ( 1 ) : 60 -70.
  • 10Keitner GI, Garlow S J, Ryan CE, et al. A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression[J]. J Psychiatr Res,2009 , 43(3) :205-214.

共引文献186

同被引文献135

引证文献14

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部